Posterior reversible leukoencephalopathy syndrome induced by L-asparaginase in a teenage female diagnosed with acute lymphoblastic leukemia;Síndrome de leucoencefalopatía posterior reversible inducida por L-asparaginasa en una adolescente diagnosticada de leucemia linfoblástica aguda

Revista de Neurologia

Volumn 52, Issue 1, 2011, Pages 58-60

  Titos Arcos, José Carlos ^a   León Villar, Josefa ^a   Amigo Lozano, M Luz ^a   Muiña Juárez, Begoña ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; CASE REPORT; DRUG INDUCED DISEASE; FEMALE; HUMAN; LETTER; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME;

EID: 79952205042     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5201.2010420     Document Type: Letter

References (21)

1. Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Böhles H. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2003; 25: 484-7. (Pubitemid 36682755)
2. Haskell CM, Canellos GP, Leventhal BG, Carbone PP, Block JB, Serpick AA, et al. L-asparaginase therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med 1969; 281: 1028-34.
3. Saito M, Hidesaku A, Hiroshi J, Uotani C, Kumabashiri lto K, Matsuda T. Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy. Am J Hematol 1989; 32: 20-3. (Pubitemid 19225930)
4. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500. (Pubitemid 26067737)
5. Edwars MJJ, Walker R, Vinnicombe S, Barlow C, MacCallum P, Foran JM. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 2001; 12: 1327-9. (Pubitemid 32994765)
6. López-García F, Amorós-Martínez F, Sempere AP. Síndrome de leucoencefalopatía posterior reversible. Rev Neurol 2004; 38: 261-6.
7. Mabie WC. Management of acute severe hypertension and encephalopathy. Clin Obstet Gynecol 1999; 42: 519-31. (Pubitemid 30017273)
8. Grivé E, Rovira-Cañellas A, Acebedo G, Álvarez- Sabín J. Leucoencefalopatía reversible relacionada con el tratamiento con ciclosporina. Rev Neurol 1997; 25: 471-3. (Pubitemid 27181869)
9. Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002; 249: 1563-6. (Pubitemid 35477899)
10. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 1999; 52: 1285-8. (Pubitemid 29177940)
11. Utz N, Kinkel B, Hedde JP, Bewermeyer H. MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology 2001; 43: 1059-62. (Pubitemid 33133644)
12. Caminero AB. Síndrome de encefalopatía posterior reversible. Neurología 2005; 20: 327-31.
13. García-Martín G, Serrano-Castro V, García-Carrasco E, Romero-Acebal M. Leucoencefalopatía posterior reversible: ¿debe ser la localización un factor definitorio? Neurología 2007; 22: 122-5.
14. Hualde-Olascoaga J, Molins-Castiella T, Souto-Hernández S, Becerril-Moreno F, Yoldi-Petri ME, Sagaseta de Ilurdoz M, et al. Leucoencefalopatía posterior reversible: descripción de dos casos asociados a vincristina. An Pediatr 2008; 68: 282-5.
15. Hurtarte-Sandoval AR, Sáenz-Alegría RA, Hernández-Mejía J. Síndrome de leucoencefalopatía posterior reversible por preeclampsia. Rev Neurol 2009; 48: 110-1.
16. Ortiz-López EM, González-Nieto JA, Rojas-Marcos I, Blanco-Ollero A. Leucoencefalopatía posterior reversible asociada a bevacizumab. Rev Neurol 2010; 51: 117-8.
17. Gugliotta L, Mazzucconi MG, Leone G. L-asparaginase and haemostasis: a GIMEMA retrospective study on the incidence of thrombosis and haemorrhage in ALL patients. Thromb Haemost 1991; 65: 1021.
18. Nowak-Göttl U, Wolff JEA, Kuhn N, Boos J, Kehrel B, Lilienweiss V, et al. Enhanced thrombin generation, P-von Willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: predictive for venous thrombosis in asparaginase-treated children. Fibrinolysis 1994; 8: 63-5. (Pubitemid 24290743)
19. Chen CY, Zimmermann RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT. Childhood leukaemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996; 17: 295-310. (Pubitemid 26067295)
20. Rathi B, Azad RK, Vasudha N, Hissaria P, Sawlani V, Gupta RK. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia. Pediatr Neurosurg 2002; 37: 203-5. (Pubitemid 35316916)
21. Hourani R, Abboud M, Hourani M, Khalifeh H, Muwakkit S. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukaemia treatment in children. Neuropediatrics 2008; 39: 46-50. (Pubitemid 351828318)